Carlos J. Pirola

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

The metabolic-immune axis in MASH: is the macrophage signature the key to liver disease staging?

The metabolic-immune axis in MASH: is the macrophage signature the key to liver disease staging?

Journal: Journal of lipid research

Published: July 01, 2026

Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality.

Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality.

Journal: Gut

Published: March 02, 2026

Beyond the canonical sequence: IsomiRs as modulators and drivers of MASLD progression: Editorial on "MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD".

Beyond the canonical sequence: IsomiRs as modulators and drivers of MASLD progression: Editorial on "MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD".

Journal: Clinical and molecular hepatology

Published: January 13, 2026

Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology.

Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology.

Journal: Med (New York, N.Y.)

Published: January 07, 2026

Sex-specific cardiometabolic phenotypes in MASLD: 3PM-centric stratification and trajectory mapping for proactive risk assessment.

Sex-specific cardiometabolic phenotypes in MASLD: 3PM-centric stratification and trajectory mapping for proactive risk assessment.

Journal: The EPMA journal

Published: December 30, 2025

Author Correction: Towards a reference cell atlas of liver diversity over the human lifespan.

Author Correction: Towards a reference cell atlas of liver diversity over the human lifespan.

Journal: Nature reviews. Gastroenterology & hepatology

Published: October 23, 2025

Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity.

Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity.

Journal: Clinical and molecular hepatology

Published: August 27, 2025

Towards a reference cell atlas of liver diversity over the human lifespan.

Towards a reference cell atlas of liver diversity over the human lifespan.

Journal: Nature reviews. Gastroenterology & hepatology

Published: August 11, 2025

Repurposing daclatasvir for MASLD Therapy-A promising step forward with challenges ahead.

Repurposing daclatasvir for MASLD Therapy-A promising step forward with challenges ahead.

Journal: Journal of lipid research

Published: July 05, 2025

Organ damage proteomic signature identifies patients with MASLD at risk of systemic complications.

Organ damage proteomic signature identifies patients with MASLD at risk of systemic complications.

Journal: Hepatology (Baltimore, Md.)

Published: February 14, 2025

Identifying molecular pathways of olfactory dysfunction in Parkinson's disease through a systems biology framework.

Identifying molecular pathways of olfactory dysfunction in Parkinson's disease through a systems biology framework.

Journal: Neuroscience

Published: February 06, 2025

MASLD as a non-communicable disease.

MASLD as a non-communicable disease.

Journal: Nature reviews. Gastroenterology & hepatology

Published: February 05, 2025

Showing 1-12 of 127

Last Updated: 09/26/2026